TB-500 upregulates VEGF and actin-binding proteins to initiate new capillary formation, while BPC-157 stabilises and organises the resulting vascular networks through its endothelial repair and VEGFR2 signalling activity
the commercial product (Geref) was voluntarily discontinued in 2008 for commercial reasons, not safety concerns, and the FDA confirmed the withdrawal was not due to efficacy or safety failures
One honest tip from our review
Peptide therapy has recently gone mainstream thanks to popular peptides like semaglutide (Ozempic) and tirzepatide (Mounjaro)
Whether your symptoms are related to diabetes, B12 deficiency, medication use or age related factors, taking steps to support nerve health can make a meaningful difference to daily life
The Elevated Dose is 4.8 mg (15 units), 5x per week